Research and Markets has announced the addition of the "Recent Advances in Gene Therapy - Genetic Technology TOE" report to their offering.

This edition of the Genetic Technology TOE depicts a range of therapeutics, developed using gene-based technologies. A strategic overview of the gene therapy market is included. The companies profiled in this issue are the current key companies in the gene therapy space. The corresponding patent scenario is depicted, along with the industry interactions.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Key Topics Covered:

Technology Profiles

- Gene Therapy for Rare Disease

- Gene Therapy for Cerebral Adrenoleukodystrophy

- Hemophilia B Gene Therapy

- Gene Therapy for Parkinson's Disease

Appendix

- Patent Scenario

- Patent Scenario

- Industry Interactions

For more information about this report visit http://www.researchandmarkets.com/research/gkwplp/recent_advances